HOME >> BIOLOGY >> NEWS
Snapshot of new drug marks a major advance by Memorial Sloan-Kettering researchers

step in this research," Dr. Finnin said, "is to dissect this complex to understand its function."

"There are a slew of biological problems that remain to be solved," added Dr. Rifkind. "We don't know, for instance, why SAHA influences the activities of only certain genes, and why SAHA is so selective for cancer cells. But we can say that SAHA is a very promising potential drug. And this latest work provides a clear pathway for the development of these agents as substances that can be used to help patients."

The planned clinical trial of SAHA - under the direction of Dr. William Kevin Kelly and Dr. Howard I. Scher, of the Genitourinary Oncology Service, and Dr. David R. Spriggs, of the Developmental Chemotherapy Service - is expected to start this fall. It is a Phase I trial, designed primarily to determine the drug's safety as a cancer treatment and to begin to understand its effects on different types of cancer, including those of the prostate, breast, and lung.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest institution devoted to patient care, research, and education in cancer. Throughout its long, distinguished history, the Center has played a leadership role in defining the standards of care for patients with cancer. In 1999, Memorial Sloan-Kettering was named the nation's best cancer center for the seventh consecutive year by U.S. News & World Report.


'"/>

Contact: Christine Westerman
publicaffairs@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
8-Sep-1999


Page: 1 2 3

Related biology news :

1. The Best Molecular Snapshot Yet Of Cells Affected By Alzheimers Disease
2. Measurement Technique Provides Snapshot Of Cell Physiology
3. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
4. X marks the spot: Vector insertion is viral specific
5. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
6. High Flux Isotope Reactor marks 400th cycle
7. Study marks increased trends in infectious disease occurrences in our oceans
8. Making of mouse marks move toward mitochondrial medicine
9. Over land, sea and air, users give MERIS high marks
10. An eye for scent marks
11. Allergen-free shrimp? seafood marks a place in food safety research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: